NCT06060106

Brief Summary

Endoscopic submucosal dissection (ESD) is a minimally invasive alternative to esophagectomy for early esophageal squamous cell carcinoma (EESCC), The data of EESCC patients who received ESD or esophagectomy were retrospectively analyzed,The aim of this study was to compare the efficacy and safety of ESD and esophagectomy in EESCC,Risk factors affecting the prognosis of patients with early esophageal squamous cell carcinoma were analyzed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
191

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 15, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 29, 2023

Completed
Last Updated

September 29, 2023

Status Verified

September 1, 2023

Enrollment Period

10 years

First QC Date

June 15, 2023

Last Update Submit

September 27, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • overall survival (OS)

    OS was measured from the date of ESD or esophagectomy until death from any cause

    10 years

  • Disease specific survival (DSS)

    DSS was measured from the date of ESD or esophagectomy until death resulting from ESCC

    10 years

  • Recurrence free survival (RFS)

    RFS was measured from the date of ESD or esophagectomy until the first recurrence or metastasis

    10 years

Secondary Outcomes (5)

  • postoperative complications

    30 days

  • R0 resection

    15 days

  • adjuvant therapy

    10 years

  • operation time

    12 hours

  • Post-operative hospitalization days

    30 days

Study Arms (2)

Endoscopic submucosal dissection

Early esophageal cancer patients treated with ESD

Procedure: Endoscopic submucosal dissection

Esophagectomy

Early esophageal cancer patients treated with esophagectomy

Procedure: Esophagectomy

Interventions

The patient was positioned in the left lateral decubitus position.Marking dots were made with a dual knife/hybrid knife around the lesion, and a solution of glycerin fructose with indigo carmine was injected into the submucosal layer to lift the lesion. Finally, after pre-cutting of the mucosal and submucosal layers around the lesion and dissection of the submucosa, the lesion was removed en bloc.

Endoscopic submucosal dissection
EsophagectomyPROCEDURE

The main surgical methods of esophagectomy include the McKeown operation, Lvor-lewis, Sweet and minimally invasive radical resection of esophageal cancer (MIE)

Esophagectomy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with early esophageal cancer from January 2011 to January 2021 admitted to Changhai Hospital were included in this study.Patients treated with ESD were classified as the ESD group, and those who underwent radical esophageal cancer treatment were classified as the surgical group.

You may qualify if:

  • Mucosal or submucosal squamous cell carcinoma of the esophagus
  • no lymph node involvement or distant metastasis on computed tomography (CT) or pathology;

You may not qualify if:

  • Tis premalignant lesions (high-grade intraepithelial neoplasia;HGIN)
  • patients with neoadjuvant therapy
  • patients combined with severe diseases of other organs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changhai Hospital, Naval Medical University

Shanghai, China

Location

Related Publications (4)

  • Zhang Y, Ding H, Chen T, Zhang X, Chen WF, Li Q, Yao L, Korrapati P, Jin XJ, Zhang YX, Xu MD, Zhou PH. Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort. Clin Gastroenterol Hepatol. 2019 Jan;17(1):73-81.e3. doi: 10.1016/j.cgh.2018.04.038. Epub 2018 Apr 25.

    PMID: 29704682BACKGROUND
  • An W, Liu MY, Zhang J, Cui YP, Gao J, Wang LP, Chen Y, Yang LX, Chen HZ, Jin H, Liu F, Chen J, Li ZS, Wang LW, Shi XG, Sun C. Endoscopic submucosal dissection versus esophagectomy for early esophageal squamous cell carcinoma with tumor invasion to different depths. Am J Cancer Res. 2020 Sep 1;10(9):2977-2992. eCollection 2020.

    PMID: 33042630BACKGROUND
  • Liu Z, Zhao R. Endoscopic Submucosal Dissection vs. Surgery for Superficial Esophageal Squamous Cancer: A Systematic Review and Meta-Analysis. Front Oncol. 2022 Apr 21;12:816832. doi: 10.3389/fonc.2022.816832. eCollection 2022.

    PMID: 35530330BACKGROUND
  • Qian M, Feng S, Zhou H, Chen L, Wang S, Zhang K. Endoscopic submucosal dissection versus esophagectomy for t1 esophageal squamous cell carcinoma: a propensity score-matched analysis. Therap Adv Gastroenterol. 2022 Nov 21;15:17562848221138156. doi: 10.1177/17562848221138156. eCollection 2022.

    PMID: 36458047BACKGROUND

MeSH Terms

Conditions

Esophageal Neoplasms

Interventions

Endoscopic Mucosal ResectionEsophagectomy

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Wei An, Doctor

    Changhai Hospital, Naval Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Gastroenterology,Changhai Hospital;Academician of Chinese Academy of Engineering

Study Record Dates

First Submitted

June 15, 2023

First Posted

September 29, 2023

Study Start

January 1, 2011

Primary Completion

January 1, 2021

Study Completion

January 1, 2023

Last Updated

September 29, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations